Score Overview
See the full market ranking โ
Trevi Therapeutics Inc fundamental performance
Across Trevi Therapeutics Inc's full reported history, from 2019 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 26M to -$ 42M. Revenue increased in 0% of the years measured; net income in 43%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 17.73 | โ |
1 Year2025-08-12 | $ 7.33 | 141.88% |
5 Years2021-08-12 | $ 2.10 | 8x |
All Time2019-05-07 | $ 7.89 | 124.71% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-05-07 |
|---|---|---|---|---|
| Price | $ 17.73 | $ 7.33 | $ 2.10 | $ 7.89 |
| Return | โ | 141.88% | 8x | 124.71% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 51M | $ 318M |
| 2025 | $ 0.00 | -$ 42M | $ 188M |
| 2024 | $ 0.00 | -$ 47M | $ 107M |
| 2023 | $ 0.00 | -$ 29M | $ 82M |
| 2022 | $ 0.00 | -$ 29M | $ 120M |
| 2021 | $ 0.00 | -$ 33M | $ 36M |
| 2020 | $ 0.00 | -$ 32M | $ 45M |
| IPO2019 | $ 0.00 | -$ 26M | $ 57M |
Explore beyond TRVI
You're looking at Trevi Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
